Schmitt U, Dahmen N, Fischer V, Weigmann H, Rao M L, Reuss S, Hiemke C
Department of Psychiatry, University of Mainz, Germany.
Neuropsychobiology. 1999;39(2):86-91. doi: 10.1159/000026566.
The present study evaluated chronic oral treatment of rats with haloperidol or clozapine. Drugs were given in the drinking water for a 23-day period. Rat behavior was analyzed once a week in an open field. Rats ingested either 1.7 mg/kg haloperidol or 40 mg/kg clozapine daily. Blood serum analysis revealed concentrations of 6 ng/ml for haloperidol and 22 ng/ml for clozapine at the end of the treatment. Haloperidol decreased overall activity from the onset of treatment. Clozapine showed similar effects only on the last test day. Control animals showed a slight habituation in exploration-related parameters. In conclusion, these results indicate that oral drug administration through the drinking water is a suitable mode of noninvasive chronic treatment that led to sufficiently high drug levels to induce specific pharmacological effects in rats.
本研究评估了用氟哌啶醇或氯氮平对大鼠进行慢性口服治疗的效果。药物通过饮用水给药,为期23天。每周在旷场中分析大鼠的行为。大鼠每天摄入1.7mg/kg氟哌啶醇或40mg/kg氯氮平。血清分析显示,治疗结束时氟哌啶醇浓度为6ng/ml,氯氮平浓度为22ng/ml。从治疗开始,氟哌啶醇就降低了总体活动量。氯氮平仅在最后一个测试日显示出类似效果。对照动物在与探索相关的参数上表现出轻微的习惯化。总之,这些结果表明,通过饮用水口服给药是一种合适的非侵入性慢性治疗方式,可使药物水平足够高,从而在大鼠中诱导特定的药理作用。